New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival OutcomesGiovanni Palladini, Giampaolo Merlini, Angela Dispenzieri et al.|Journal of Clinical Oncology|2012Cited by 965
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working GroupMeletios Α. Dimopoulos, Evangelos Terpos, Joseph Mıkhael et al.|The Lancet Oncology|2023Cited by 120
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndromeMarit Jalink, Josephine M. I. Vos, Sigbjørn Berentsen et al.|Blood|2021Cited by 56
Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health WorkersEvangelos Terpos, Meletios Α. Dimopoulos, Ioannis P. Trougakos et al.|Cells|2021Cited by 46
Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA TherapyIoannis Ntanasis‐Stathopoulos, Evangelos Terpos, Vangelis Karalis et al.|HemaSphere|2022Cited by 44